2 Papers
6 Citations
Y. Laabi is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Induced pluripotent stem cell & Embryonic stem cell. The author has an hindex of 2, co-authored 2 publications.
Chat about Author
Papers
Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI)
Peter W. Andrews,David Baker,N. Benvinisty,B. Miranda,K. Bruce,Oliver Brüstle,M. Choi,Y. M. Choi,Jeremy M. Crook,P.A. De Sousa,Petr Dvorak,Christian Freund,Meri T. Firpo,Miho Furue,Paul J. Gokhale,H. Y. Ha,E. Han,Simone Haupt,L. Healy,Derek J. Hei,Outi Hovatta,C. Hunt,S. M. Hwang,Maneesha S. Inamdar,Rosario Isasi,Marisa Jaconi,V. Jekerle,P. Kamthorn,M. C. Kibbey,Ivana Knezevic,B. B. Knowles,S. K. Koo,Y. Laabi,L. Leopoldo,Pentao Liu,Geoffrey P. Lomax,Jeanne F. Loring,Tenneille Ludwig,Karen Dyer Montgomery,Christine L. Mummery,Andras Nagy,Y. Nakamura,Norio Nakatsuji,Steve Oh,Sun Kyung Oh,Timo Otonkoski,Martin F. Pera,Marc Peschanski,Patricia Pranke,Kristiina Rajala,Mahendra Rao,R. Ruttachuk,Benjamin Reubinoff,L. Ricco,Heather M. Rooke,Douglas Sipp,Glyn Stacey,Hirofumi Suemori,Tsuneo Takahashi,K. Takada,S. Talib,Shelly E. Tannenbaum,B. Z. Yuan,Fanyi Zeng,Qi Zhou +64 more
TL;DR: This guidance is revisited to consider what the requirements would be for delivery of the early seed stocks of stem cell lines intended for clinical applications.
The Implementation of Novel Collaborative Structures for the Identification and Resolution of Barriers to Pluripotent Stem Cell Translation
David Brindley,Anna French,J Suh,Mackenna Roberts,Benjamin Davies,Rafael Pinedo-Villanueva,Karolina Wartolowska,K Rooke,A Kramm,Andrew Judge,Mark E. Morrey,Amit Chandra,Hannah Hurley,Liam M. Grover,I Bingham,B Siegel,M S Rattley,R L Buckler,D McKeon,K Krumholz,L Hook,M May,Sarah Rikabi,R Pigott,M Morys,Afsie Sabokbar,E Titus,Y. Laabi,Gilles Lemaitre,R Zahkia,Douglas Sipp,Rob Horne,Christopher A. Bravery,David J. Williams,Ivan B. Wall,Evan Y. Snyder,Jeffrey M. Karp,Richard W. Barker,Kim Bure,Andrew Carr,Brock Reeve +40 more
TL;DR: Initial findings for all research focus areas are presented to inform global product development strategies, and to stimulate continued industry interaction around biomanufacturing, strategic partnerships, standards, regulation and intellectual property and clinical adoption.